Evaluation of nuclear unrest and p53 immunostaining in wilms’ tumor

Abstract EN

Background : nuclear unrest is a term applied to Wilms’ tumors (WT) that show nuclear abnormalities close to anaplasia but without abnormal mitoses.

P 53 is claimed to be associated with anaplasia and poor prognosis.

This study was undertaken to evaluate the clinical significance of nuclear unrest and p53 immunostaining in Wilms’ tumor.

Material and methods : this is a retrospective study of 63 patients who presented at NCI with Wilms’ tumors, and underwent preoperative chemotherapy followed by nephrectomy.

Histopathology assessment and p53 immunohistochemistry were done.

Results : WT with nuclear unrest grade III closely resembled anaplastic tumors and both of them (group 1) constituted 19 % of cases.

Group 1 constituted 29 % of cases showing blastema dominant morphology compared to 9.4 % of cases without blastema dominant morphology with significant statistical difference (p = 0.047).

Almost 83% of cases that achieved 1st complete remission were stages I, II and III, while 17 % were stages IV and V with significant statistical difference (p < 0.001).

Stage affected the 3-year relapse-free-survival (RFS) significantly (p = 0.014) as it was more in stages I, II and III than in stages IV and V (75.4 % versus 50 %).

Blastema dominant morphology and high risk state significantly lowered the 3-year overall survival (OS) into 54.8 % in comparison to 80.9% for cases with non-blastema dominant morphology (p = 0.042).

Regarding p53 immunohistochemistry, group 1 tumors showed positive p53 more than group 2 with significant statistical difference (p= 0.014).

p 53 Positive immunostaining was significantly associated with high risk nephroblastoma (p = 0.004).

Conclusion : Tumor stage and blastema dominant morphology are potent prognostic factors.

P 53 is linked to blastema dominant morphology.

WT with nuclear unrest grade III closely resembles anaplastic WT.

It may be appropriate to group tumors with nuclear unrest grade III with anaplastic histology regarding treatment stratification.

ª 2011 National Cancer Institute, Cairo University.

Production and Hosting by Elsevier B.V.

All rights reserved.